Regulation of glutathione synthesis by a mechanism of cysteine depletion or inhibition of glutaminolysis is in part controlled by sirtuin 5 (SIRT5) and is a targetable metabolic vulnerability in AML (38, 45). Here, SIRT5 is linked to acute myeloid leukemia.